(Q36011590)

11 August 2017

A Randomized Multicenter Study Comparing a Tacrolimus-Based Protocol with and without Steroids in HCV-Positive Liver Allograft Recipients (English)

1 reference

multicenter clinical trial

11 August 2017

0 references

author name string

Ulf Neumann

1

1 reference

11 August 2017

Didier Samuel

2

1 reference

11 August 2017

Pavel Trunečka

3

1 reference

11 August 2017

Jean Gugenheim

4

1 reference

11 August 2017

Giorgio Enrico Gerunda

5

1 reference

11 August 2017

Styrbjörn Friman

6

1 reference

11 August 2017

28 May 2012

1 reference

Journal of transplantation

11 August 2017

1 reference

11 August 2017

2012

1 reference

11 August 2017

894215

1 reference

Creative Commons Attribution 3.0 Unported

11 August 2017

start time

1 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

copyrighted

0 references

cites work

Risk factors for hepatitis C recurrence after liver transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368368

Early recurrence of hepatitis C virus infection after liver transplantation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368368

Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368368

Slowly tapering off steroids protects the graft against hepatitis C recurrence after liver transplantation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368368

Histological grading and staging of chronic hepatitis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368368

Prediction of creatinine clearance from serum creatinine

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368368

Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368368

A model to predict severe HCV-related disease following liver transplantation.

11 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F894215

The course of hepatitis C virus infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F894215

Repeated steroid pulse therapies in HCV-positive liver recipients: significant risk factor for HCV-related graft loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F894215

A prospective randomized trial comparing tacrolimus and steroids with tacrolimus monotherapy in liver transplantation: the impact on recurrence of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F894215

Influence of steroids on HCV recurrence after liver transplantation: A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F894215

Fibrosis progression after liver transplantation in patients with recurrent hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F894215

Timing of reinfection and mechanisms of hepatocellular damage in transplanted hepatitis C virus-reinfected liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F894215

Double-blind comparison of hepatitis C histological recurrence Rate in HCV+ Liver transplant recipients given basiliximab + steroids or basiliximab + placebo, in addition to cyclosporine and azathioprine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F894215

Corticosteroid-free immunosuppression with tacrolimus following induction with daclizumab: a large randomized clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F894215

Corticosteroid-free immunosuppression with daclizumab in HCV(+) liver transplant recipients: 1-year interim results of the HCV-3 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F894215

Liver transplantation in the United States, 1999-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F894215

Effect of calcineurin inhibitors on survival and histologic disease severity in HCV-infected liver transplant recipients.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368368

Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: results from a prospective multicenter randomized study

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368368

Hepatitis C and liver transplantation

23 September 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F894215

Recurrent hepatitis C post-liver transplant: the lessons learned

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22690326

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1155/2012/894215

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

22690326

1 reference